Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06736548 · ClinicalTrials.gov registry record · NA

Sleep Treatment Education Program for Cancer Survivors: STEP-Together

A NA study of Insomnia and Survivorship, sponsored by Dana-Farber Cancer Institute.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06736548 is a NA study of Insomnia and Survivorship that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 100 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06736548, a NA study of Insomnia and Survivorship, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This single-arm research study of off-treatment cancer survivors with self-reported symptoms of insomnia will test the Sleep Treatment Education Program Together (STEP-Together) intervention which is delivered as a synchronous group session by videoconference.

Interventions

  • BEHAVIORAL The Sleep Treatment Education Program Together (STEP-Together)
  • BEHAVIORAL Coaching Session

Study Locations (1)

Massachusetts

  • Dana Farber Cancer Institute - Boston

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-06-25
Est. Completion 2026-12-31
Phase NA

Sponsor

Dana-Farber Cancer Institute

781 total trials

What the Registry Record Tells You About NCT06736548

The ClinicalTrials.gov registry entry for NCT06736548 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (41% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which The Sleep Treatment Education Program Together (STEP-Together) is the first listed.

NCT06736548 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06736548 about?

NCT06736548 is a clinical study titled "Sleep Treatment Education Program for Cancer Survivors: STEP-Together". This single-arm research study of off-treatment cancer survivors with self-reported symptoms of insomnia will test the Sleep Treatment Education Program Together (STEP-Together) intervention which is delivered as a synchronous group session by videoconference.

What is the current status of trial NCT06736548?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-06-25. Estimated completion is 2026-12-31.

What conditions does trial NCT06736548 study?

This clinical trial studies the following conditions: Insomnia, Survivorship, Insomnia Chronic.

What interventions are being tested in trial NCT06736548?

The interventions under investigation include: The Sleep Treatment Education Program Together (STEP-Together) (BEHAVIORAL), Coaching Session (BEHAVIORAL).

Who is sponsoring clinical trial NCT06736548?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06736548 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.